Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Addison Tolentino"'
Autor:
Addison Tolentino, Apar Kishor Ganti, Irfan Vaziri, Danstan Bagenda, Chao M.D. Huang, Jhanelle E. Gray, Poppy E. Deviany, Ann Fetrick, Heidi McKean, K. M. Islam, Mehmet Sitki Copur, June Ryan, Steven Dunder, Trisari Anggondowati
Publikováno v:
Journal of Oncology Practice. 15:e758-e768
PURPOSE: In the United States, lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Because no cure exists for advanced lung cancer, the primary treatment goal is to prolong survival. OBJECTIVES: The study aim was to de
Autor:
Marsha A. Ketcham, Alissa S. Marr, Anne Kessinger, Mary M. Huerter, Addison Tolentino, Karin Swenson, Holly DeSpiegelaere, Jane L. Meza, M. Sitki Copur, Apar Kishor Ganti, Susan Kruse, Mary E. Kos, Sarah E. Radniecki
Publikováno v:
Journal of Geriatric Oncology. 8:18-22
Objective Platinum-based doublet chemotherapy is the standard for most patients with advanced non-small cell lung cancer (NSCLC). Toxicity concerns limit chemotherapy for patients over 70 years. Vinorelbine and paclitaxel are effective as single agen
Autor:
Samuel T. Opoku, Irfan Vaziri, K. M. Islam, Mehmet Sitki Copur, Apar Kishor Ganti, Bettye A. Apenteng, June Ryan, Addison Tolentino, Ann Fetrick
Publikováno v:
Journal of Cancer Education. 31:554-558
Although lung cancer is the leading cause of cancer death in the USA, there have been few studies on patient-centered advanced lung cancer treatment practices. As part of a larger research study on how to use a patient-inclusive approach in late-stag
Autor:
Mehmet Sitki Copur, Bettye A. Apenteng, K. M. Islam, Samuel T. Opoku, June Ryan, Apar Kishor Ganti, Irfan Vaziri, Addison Tolentino, Ann Fetrick
Publikováno v:
Journal of Cancer Education. 29:796-801
Participatory and patient-centered approaches to cancer research have been highlighted as the most appropriate means of engaging patients in the conduct of clinical research. However, there is a paucity of patient-centered outcomes research (PCOR) on
Autor:
Mehmet Sitki Copur, Ann Fetrick, Addison Tolentino, Irfan Vaziri, June Ryan, Apar Kishor Ganti
Publikováno v:
International Journal of Cancer Studies & Research. :31-35
Background: In 2013, researchers at the University of Nebraska Medical Center (UNMC) received funding from the Patient-Centered Outcomes Research Institute to establish a study that outlines treatment options for patients who have stage IV lung cance
Publikováno v:
World Journal of Clinical Oncology
Driver mutations in patients with non-small cell lung cancer (NSCLC) can lead to distinct behaviors and patterns of metastasis. Mutations in the proto-oncogene B-raf (BRAF) occur in approximately 3% of NSCLC cases. In the literature, reports of patie
Background: In 2013, researchers at the University of Nebraska Medical Center (UNMC) received funding from the Patient-Centered Outcomes Research Institute to establish a study that outlines treatment options for patients who have stage IV lung cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::269b0004c5fc5dead94ee952839139d6
https://zenodo.org/record/573044
https://zenodo.org/record/573044
Autor:
Marissa A. Olson, Addison Tolentino, Mark Huber, Seth Tutera, Brian Leyland-Jones, Heidi McKean, Casey Williams
Publikováno v:
Cancer Research. 75:5494-5494
Purpose Cancer represents a significant burden on the economy. The NCI estimated that this cost will exceed $158 billion in 2020. As cancer-related costs increase, it is pertinent to explore alternative treatment strategies. The advent of cancer geno